Work

The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial

Year: 2026

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-25-4770

Authors: Zhimin Zeng, Wenqian Huang, Fujuan Zeng, Le Xiong, Chenyi Liu, Ziye Chen, Yue’e Zheng, Jing Cai, Long Huang, Xiaoqiang Zhang, Anwen Liu

Institutions: Nanchang University, Second Affiliated Hospital of Nanchang University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7141568062

FWCI: 4.379

Cites: 63

Cited by: 1

Related to: